Trilogy Capital’s First Trust Financials AlphaDEX Fund FXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-5,588
Closed -$242K – 313
2023
Q4
$242K Sell
5,588
-420
-7% -$16.4K 0.02% 233
2023
Q3
$227K Buy
+6,008
New +$237K 0.02% 244

Other funds holding FXO

Trilogy Capital's FXO Position: Q1 2024 in Review

Trilogy Capital sold out of First Trust Financials AlphaDEX Fund (FXO) in Q1 2024, closing a stake of 5,588 shares — an estimated $242K sold.

Trilogy Capital first reported a position in FXO in Q3 2023 and held it in 2 quarters. The position peaked at $242K in Q4 2023. 186 funds tracked by Wall St. Rank hold FXO as of Q1 2024.

  • Trilogy Capital reported no remaining First Trust Financials AlphaDEX Fund position as of Q1 2024 after selling out during the quarter.
  • Trilogy Capital sold 5,588 First Trust Financials AlphaDEX Fund shares in Q1 2024, an estimated $242K.
  • Trilogy Capital first reported a position in First Trust Financials AlphaDEX Fund in Q3 2023 and held it in 2 quarters.
  • Trilogy Capital's First Trust Financials AlphaDEX Fund position peaked at $242K in Q4 2023.
  • 186 funds tracked by Wall St. Rank held First Trust Financials AlphaDEX Fund as of Q1 2024.

Based on Trilogy Capital's 13F filing for Q1 2024, filed 17 Apr 2024.